2011
DOI: 10.4161/isl.3.4.15875
|View full text |Cite
|
Sign up to set email alerts
|

Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects

Abstract: Key words: immunocytochemistry, islet amyloid polypeptide, pancreatic islets, type 1 diabetes injection compliments insulin treatment to have a better glycemic control through suppressing glucagon secretion. This study was aimed to investigate the possible IAPP deficient pancreatic islets being responsible for severe IAPP hyposecretion in type 1 diabetics. Results Control islets.Large control islets consisted of major insulin cells, followed by glucagon and SRIF cells at a relative ratio of 6:3:1 whereas in me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
30
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(32 citation statements)
references
References 21 publications
2
30
0
Order By: Relevance
“…The pancreas was obtained at autopsy from T1D subjects of ages 18 to 75, and the immunocytochemical presence of ACC suggests that ACC mediated apoptosis was in the ongoing process even at the subjects' death with a delicate balance of β-cell apoptosis and regeneration. These data also support that β-cell apoptosis and regeneration process is progressive from the preclinical stage to the end-stage of T1D and T2D 40,41 . The ACC positive β-islet cells were more in type 1 diabetic islets than in type 2 diabetic islets [39][40][41] .…”
Section: Immunocytochemical Studysupporting
confidence: 68%
See 4 more Smart Citations
“…The pancreas was obtained at autopsy from T1D subjects of ages 18 to 75, and the immunocytochemical presence of ACC suggests that ACC mediated apoptosis was in the ongoing process even at the subjects' death with a delicate balance of β-cell apoptosis and regeneration. These data also support that β-cell apoptosis and regeneration process is progressive from the preclinical stage to the end-stage of T1D and T2D 40,41 . The ACC positive β-islet cells were more in type 1 diabetic islets than in type 2 diabetic islets [39][40][41] .…”
Section: Immunocytochemical Studysupporting
confidence: 68%
“…These data also support that β-cell apoptosis and regeneration process is progressive from the preclinical stage to the end-stage of T1D and T2D 40,41 . The ACC positive β-islet cells were more in type 1 diabetic islets than in type 2 diabetic islets [39][40][41] .…”
Section: Immunocytochemical Studysupporting
confidence: 68%
See 3 more Smart Citations